Upregulated Expression of Circulating MicroRNAs in Kidney Transplant Recipients With Interstitial Fibrosis and Tubular Atrophy

Authors

  • Sepideh Zununi Vahed Kidney Research Center; School of Advanced Biomedical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran Author
  • Ahmad Poursadegh Zonouzi Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Author
  • Hossein Ghanbarian School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran Author
  • Moteza Ghojazadeh Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Author
  • Nasser Samadi School of Advanced Biomedical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran Author
  • Mohammadreza Ardalan Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Author

Abstract

Introduction. The discovery of circulating microRNAs (miRNAs), as potential noninvasive diagnostic biomarkers, has opened new avenues of research for identifying transplant patients with chronic allograft dysfunction. The present study aimed to investigate the expression levels of 4 immune-related miRNAs, miR-21, miR-31, miR-142-3p, and miR-155, in plasma samples of kidney allograft recipients.

Materials and Methods. The plasma expression levels of the miRNAs were evaluated by quantitative real-time polymerase chain reaction in 53 kidney recipients with long-term stable allograft function (n = 27), biopsy-proven interstitial fibrosis and tubular atrophy (n = 26), and healthy controls (n = 15). The possible correlation between clinical parameters and the circulating miRNAs and the receiver-operating characteristic analysis were performed.

Results. Significantly upregulated expressions of miR-21 (P = .02), miR-142-3p (P = .048), and miR-155 (P = .005) were observed in plasma samples of recipients with interstitial fibrosis and tubular atrophy in comparison to the stable allograft function and healthy control groups. Expression level of the miR-21 in plasma was correlated with creatinine (r = -0.432, P = .03) and estimated glomerular filtration rate (r = 0.423, P = .031). Multivariable analysis indicated that miR-21, miR-142-3p, and miR-155 in plasma samples could discriminate almost most of the patients with interstitial fibrosis and tubular atrophy (area under curve, 0.802; sensitivity, 81%; specificity, 92%).

Conclusions. Our data suggested that altered expression of miR-21, miR-142-3p, and miR-155 in plasma samples might be associated with kidney allograft dysfunction and could be used for graft monitoring in kidney transplantation.

Downloads

Download data is not yet available.

Downloads

Published

2017-06-02

Issue

Section

ORIGINAL | Transplantation

How to Cite

Upregulated Expression of Circulating MicroRNAs in Kidney Transplant Recipients With Interstitial Fibrosis and Tubular Atrophy. (2017). Iranian Journal of Kidney Diseases, 11(4), 309-318. https://www.ijkd.org/index.php/ijkd/article/view/2991

Most read articles by the same author(s)